...
首页> 外文期刊>Cell death & disease. >MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer
【24h】

MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer

机译:MiR-133b靶向Sox9以控制乳腺癌的发病机理和转移

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The miR-133b, a commonly recognized muscle-specific miRNA, was reported to be deregulated in many kinds of cancers. However, its potential roles in tumorigenesis remain greatly elusive. Herein, we demonstrate that miR-133b is significantly suppressed in human breast cancer specimens, which is reversely correlated to histological grade of the cancer. Ectopic expression of miR-133b suppresses clonogenic ability and metastasis-relevant traits in vitro, as well as carcinogenesis and pulmonary metastasis in vivo. Further studies have identified Sox9, c-MET, and WAVE2 as direct targets of miR-133b, in which Sox9 contributes to all miR-133b-endowed effects including cell proliferation, colony formation, as well as cell migration and invasion in vitro. Moreover, re-expression of Sox9 reverses miR-133b-mediated metastasis suppression in vivo. Taken together, these findings highlight an important role for miR-133b in the regulation of tumorigenesis and metastatic potential of breast cancer and suggest a potential application of miR-133b in cancer treatment.
机译:据报道,miR-133b是一种公认​​的肌肉特异性miRNA,在许多类型的癌症中均被解除调控。但是,其在肿瘤发生中的潜在作用仍然难以捉摸。在本文中,我们证明了miR-133b在人乳腺癌标本中得到了显着抑制,这与癌症的组织学等级成反比。 miR-133b的异位表达在体外可抑制克隆形成能力和转移相关性状,在体内可抑制癌变和肺转移。进一步的研究已确定Sox9,c-MET和WAVE2是miR-133b的直接靶标,其中Sox9参与了所有miR-133b赋予的作用,包括细胞增殖,集落形成以及细胞在体外的迁移和侵袭。此外,Sox9的重新表达在体内逆转了miR-133b介导的转移抑制。综上所述,这些发现突出了miR-133b在调节乳腺癌的发生和转移潜能方面的重要作用,并暗示了miR-133b在癌症治疗中的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号